Research Articles | Page 27 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
High-dose Romiplostim Accelerates Hematologic Recovery in Patients With Aplastic Anemia Refractory to Eltrombopag Jul 2020 Leukemia Aplastic Anemia
High Serum Ferritin Levels in Newly Diagnosed Patients With Myelodysplastic Syndromes Are Associated With Greater Symptom Severity Jun 2020 International Journal of Hematology Myelodysplastic Syndromes (MDS)
High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity Aug 2020 International Journal of Hematology Myelodysplastic Syndromes (MDS)
Heterogeneity in Health-Related Quality of Life of Patients with Aplastic Anemia: A Latent Profile Analysis Mar 2025 Patient Preference and Adherence Aplastic Anemia
Hemolysis events in the Phase 3 PEGASUS study of pegcetacoplan in patients with paroxysmal nocturnal hemoglobinuria Apr 2024 Blood Advances Paroxysmal Nocturnal Hemoglobinuria (PNH)
Hematopoietic Cell Transplantation With Cryopreserved Grafts for Severe Aplastic Anemia May 2020 Biology of blood and marrow transplantation: journal of the America Society of Blood and Marrow Transplantation Aplastic Anemia
Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab. Feb 2019 Biol Blood Marrow Transplant. Paroxysmal Nocturnal Hemoglobinuria (PNH)
Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study Jul 2023 Blood Advances Myelodysplastic Syndromes (MDS)
Health-Related Quality of Life and Vulnerability among People with Myelodysplastic Syndromes: A US National Study May 2023 Blood Advances Myelodysplastic Syndromes (MDS)
Health-related quality of life and symptom-specific functional impairment among patients treated with parenterally administered complement inhibitors for paroxysmal nocturnal hemoglobinuria Nov 2024 Annals of Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)